UCLP Centre for Neurorehabilitation seminar: Dr Kayla Cornett
Clinical trial readiness for Charcot-Marie-Tooth disease: Sustaining reliable clinical outcome assessments with an online training and accreditation program
Hybrid event*
Free registration through Eventbrite
*For those attending in person, the seminar will take place in the Basement Lecture Theatre, 33 Queen Square, London WC1N 3BG. Join us after the seminar for wine, soft drinks, crisps and networking. For those attending virtually, the Zoom link will be sent via email to those who have registered closer to the event.
Please send any enquiries to: cnr@ucl.ac.uk
Inaccurate measurement causes unnecessary delays in the translation of new therapies. There is currently no disease-modifying treatment for Charcot-Marie-Tooth disease (CMT), but clinical trials are imminent for promising therapeutic candidates. Reliable, sensitive and responsive clinical outcome assessments exist for CMT across the lifespan. To ensure rigor in these clinical outcome assessments, we developed and are implementing an online training and quality assurance program. The resources developed to train and prepare clinical evaluators will accelerate the initiation of clinical trials.
Dr Kayla Cornett
Dr Kayla Cornett PhD, MSc, BHK (Ex Phys), is a NIH funded postdoctoral research fellow at the University of Sydney and Children’s Hospital at Westmead. She is an expert in clinical outcome measurement for pediatric neuromuscular diseases. As an early career researcher Dr Cornett has over 35 publications including a seminal report published in the Annals of Neurology focusing on the natural history of Charcot-Marie-Tooth disease during childhood. She collaborates with leading researchers in Charcot-Marie-Tooth disease and Spinal Muscular Atrophy internationally with her research focusing on reliable and sensitive assessment of function in children with neuromuscular diseases.
Further information
Ticketing
Pre-booking essential
Cost
Free
Open to
All
Availability
Yes